Dopamine Shapes How Fast We Move Toward Rewards - and the Effect Shows Up 220 Milliseconds After a Surprise
The phrase "skip in your step" captures something real about how mood affects movement - but the underlying mechanism has been hard to pin down. When a pleasant surprise quickens your pace or an unexpected disappointment slows you, what exactly is happening in the brain, and how quickly does it happen?
A study published in Science Advances by Alaa Ahmed and Colin Korbisch at the University of Colorado Boulder offers a detailed mechanistic answer. Using a joystick-based reaching task and careful analysis of movement timing, the researchers found that the speed of human arm movements tracks reward prediction errors - the difference between what was expected and what was received - in a pattern that closely mirrors what is known about dopaminergic neuron activity in the brain.
The experiment design
Human subjects were asked to reach toward one of four targets on a screen using a joystick. The targets varied in how reliably they produced a reward signal - a light flash and beep. One target gave a reward on every reach; another never gave rewards; two others fell at intermediate probabilities. This design allowed the researchers to create conditions where rewards were expected, unexpected, or reliably absent.
The main finding was that people reached faster toward targets with higher reward probability - the intuitive result. But a more subtle finding emerged in the timing data: when a subject reached toward a low-probability target and unexpectedly received a reward, their movement speed increased measurably even after the reward had already been delivered. That acceleration happened within 220 milliseconds of the reward signal.
Why 220 milliseconds is significant
Dopaminergic neurons - cells in the brain's reward circuitry that release dopamine - are known from decades of animal research to fire in response to unexpected rewards and to show reduced activity when expected rewards fail to arrive. The landmark work by neuroscientist Wolfram Schultz in the 1990s, conducted in primates expecting apple juice rewards, established these "reward prediction error" responses as a fundamental feature of dopamine signaling.
The 220-millisecond window in the CU Boulder study is fast enough to be consistent with a dopamine signal generated by the unexpected reward rather than a consequence of conscious deliberation about the outcome. The effect was subtle enough that it was invisible to the naked eye - a small, statistically detectable change in movement velocity rather than an obvious lurch forward. "Movements are a window to the mind," Korbisch said. "Normally, you can't go into the brain and see what the dopaminergic neurons are doing, but movement could reflect those neural computations that are so difficult to disentangle."
Crucially, the effect depended on surprise. When subjects were certain they would receive a reward - reaching toward the always-rewarded target and getting it as expected - no second surge in movement speed appeared after the signal. "Importantly, this effect wasn't tied to reward reception alone. If the outcome was certain and known to the individual, we saw no further increase in vigor," Korbisch said. This specificity is consistent with the prediction error framework: dopamine neurons fire to unexpected good news, not to expected outcomes.
Cumulative effects and clinical implications
Past experience mattered beyond individual trials. Subjects who received a sequence of rewards over multiple reaches gradually moved faster overall; those who received mostly non-rewarding outcomes gradually slowed. This cumulative effect - movement vigor tracking accumulated reward history - mirrors how dopamine systems are thought to update behavioral policies over time based on experience.
The clinical relevance is what makes this more than a laboratory curiosity. People with Parkinson's disease lose substantial numbers of dopaminergic neurons and characteristically move slowly - a connection the researchers used as motivation for the work. Depression is also associated with psychomotor slowing. If movement kinematics reliably track dopaminergic function, they become a potential non-invasive window into a system that is otherwise only accessible through brain scanning or pharmacological challenge.
Ahmed envisions that medical professionals might eventually track patients' movement characteristics over time - through simple reaching tasks or even daily activity monitoring - as an indirect measure of dopaminergic health. Distinguishing normal day-to-day variation from the beginning of pathological decline, or tracking whether a treatment is helping, could become more accessible if movement provides a valid proxy. The current study uses a controlled joystick task; whether the same effects appear in naturalistic movement will need validation.